ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,420Medicare Part D Prescriptions Filled, Including Refills

Rank: 101 out of 288

$318K Total Retail Price of All Prescriptions

Rank: 159 out of 288

273 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
16% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 273 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

8% of this provider’s 273 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 7,892 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$38 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
SIMVASTATIN 368 365 1 1
LEVOTHYROXINE SODIUM 336 318 2 2
METOPROLOL SUCCINATE 286 282 3 15
AMLODIPINE BESYLATE 238 225 4 6
FUROSEMIDE 232 220 5 5
WARFARIN SODIUM 225 212 6 9
FOSINOPRIL SODIUM 222 217 7 166
ATORVASTATIN CALCIUM 199 187 8 14
METOPROLOL TARTRATE 189 179 9 8
METFORMIN HCL 184 176 10 12
OMEPRAZOLE 180 153 11 3
GABAPENTIN 173 133 12 17
GEMFIBROZIL 166 137 13 77
SERTRALINE HCL 162 152 14 25
ZOLPIDEM TARTRATE 159 158 15 22
LISINOPRIL 141 141 16 4
HYDROCHLOROTHIAZIDE 135 135 17 13
TAMSULOSIN HCL 124 124 18 24
PRAVASTATIN SODIUM 118 106 19 21
ALENDRONATE SODIUM 113 109 20 20
POTASSIUM CHLORIDE 112 112 21 11
PREDNISONE 93 90 22 30
TRAMADOL HCL 93 79 22 19
GLIPIZIDE ER 91 73 24 93
METFORMIN HCL ER 91 87 24 76
CRESTOR 90 87 26 26
ALLOPURINOL 87 79 27 23
FENTANYL 81 81 S2 28 57
ATENOLOL 75 75 29 10
LOSARTAN POTASSIUM 70 68 30 16
HYDROCODONE-ACETAMINOPHEN 69 66 S3 31 7
OXYBUTYNIN CHLORIDE 66 66 32 69
DILTIAZEM 24HR CD 63 63 33 75
DICLOFENAC SODIUM 61 61 34 193
ACTOS 60 57 35 106
DOXAZOSIN MESYLATE 59 51 36 78
KLOR-CON M20 58 58 37 110
DIOVAN 57 45 38 53
PAROXETINE HCL 55 55 39 54
DIOVAN HCT 55 55 39 112
CEFUROXIME 54 51 41 201
DONEPEZIL HCL 53 53 42 29
SPIRONOLACTONE 52 42 43 36
QUINAPRIL HCL 50 50 44 138
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 11, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.